Skip To Main Content
Mikhail V. Bychinin on Muck Rack

Mikhail V. Bychinin

As seen in: MDPI, The New England Journal of Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Mikhail V. Bychinin’s profile

Articles by Mikhail V. Bychinin

Alterations in the CD56− and CD56+ T Cell Subsets during COVID-19

|
By Mikhail V. Bychinin, Julia D. Vavilova, Maria O. Ustiuzhanina, Anna Boyko
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by 1, 1,2, 1, 1, 1, 1, 1, 1, Ekaterina O.
Open in Who Shared Issue with article?

Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19

|
By Anna Boyko, Mikhail V. Bychinin, Maria O. Ustiuzhanina, Julia D. Vavilova
| MDPI
Abstract : Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is accompanied by a dysregulated immune response. In particular, NK cells, involved in the antiviral response, are affected by the infection.
Open in Who Shared Issue with article?

Effect of Early Treatment with Ivermectin among Patients with Covid-19

|
By Mikhail V. Bychinin
| The New England Journal of Medicine Verified
Published March 30, 2022 N Engl J Med 2022;386:1721-1731 DOI: 10.1056/NEJMoa2115869 For permission requests, please contact NEJM Reprints at reprints@nejm.org Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against...
Open in Who Shared Issue with article?
Show More